On Monday, Ohio Attorney General Dave Yost sued six corporate entities over how they facilitate drug transactions. Yost filed the suit under the Valentine Act — Ohio’s antitrust law — accusing the companies of improperly colluding to fix prices and other actions regarding prescription drugs.
The main target of the lawsuit is St. Louis-based Express Scripts. It’s one of the three biggest drug middlemen in the United States.
Related: US: DOJ Oks Cigna/Express Scripts $52b merger
The three “pharmacy benefit managers” have a significant market share where they negotiate rebates with manufacturers and determine reimbursements to pharmacies while reconciling transactions at the drug counter.
Also being sued are Express Scripts’ corporate parents, Cigna and Evernorth, and Ascent Health Services, a “group purchasing organization” it started in 2019. In addition, the suit names as defendants Prime Therapeutics — a smaller PBM owned by Blue Cross and Blue Shield which co-owns Ascent — as well as Humana Pharmacy Solutions, an Ascent customer.
Featured News
Judge Appoints Law Firms to Lead Consumer Antitrust Litigation Against Apple
Dec 22, 2024 by
CPI
Epic Health Systems Seeks Dismissal of Antitrust Suit Filed by Particle Health
Dec 22, 2024 by
CPI
Qualcomm Secures Partial Victory in Licensing Dispute with Arm, Jury Splits on Key Issues
Dec 22, 2024 by
CPI
Google Proposes Revised Revenue-Sharing Limits Amid Antitrust Battle
Dec 22, 2024 by
CPI
Japan’s Antitrust Authority Expected to Sanction Google Over Monopoly Practices
Dec 22, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand